Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2023.03.30
ag真人平台官方：2022年度监事会工作报告
2023.03.30
ag真人平台官方：独立董事提名人声明（吕川）
2023.03.30
ag真人平台官方：独立董事候选人声明（吕川）
2023.03.30
ag真人平台官方：独立董事对担保等事项的独立意见
2023.03.30
ag真人平台官方：2022年度财务决算报告
2023.03.30
2022年年度报告
2023.03.30
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
2023.03.29
ag真人平台官方：深圳市ag真人平台官方药业集团股份有限公司2022年面向专业投资者公开发行公司债券2023年...
2023.03.28
ag真人平台官方：关于子公司签订许可协议的公告
2023.03.28
VOLUNTARY ANNOUNCEMENT ENTERING INTO LICENSE AND DISTRIBUTION AGREEMENT WITH OEP...
第一页
上一页
14
15
16
17
18
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
